RecruitingPhase 1NCT06545331
Study of XB010 in Subjects With Solid Tumors
Sponsor: Exelixis
Austin, TX · Dallas, TX · Houston, TX · +13 more sites
Breast Cancer clinical trials in Austin, TX
13 recruiting breast cancer studies with a site in Austin, TX.
RecruitingPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor: Genmab
Abilene, TX · Austin, TX · Dallas, TX · +34 more sites
RecruitingPhase 3NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sponsor: Relay Therapeutics, Inc.
Austin, TX · Dallas, TX · +49 more sites
RecruitingPhase 1NCT06270706
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Sponsor: Pliant Therapeutics, Inc.
Austin, TX · Fort Worth, TX · Houston, TX · +13 more sites
RecruitingPhase 1NCT07222267
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Sponsor: BeOne Medicines
Austin, TX · Houston, TX · +4 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Austin, TX · Houston, TX · Irving, TX · +15 more sites
RecruitingPhase 1 / Phase 2NCT06657222
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Sponsor: Gilead Sciences
Austin, TX · Irving, TX · San Antonio, TX · +10 more sites
RecruitingPhase 3NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Sponsor: Greenwich LifeSciences, Inc.
Austin, TX · Dallas, TX · +48 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Austin, TX · Dallas, TX · Fort Worth, TX · +8 more sites
RecruitingPhase 1NCT07424547
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Austin, TX · San Antonio, TX · +3 more sites
RecruitingPhase not listedNCT07318051
Sample Collection for Ongoing Research and Product Evaluation Study
Sponsor: Natera, Inc.
Austin, TX
RecruitingPhase 1NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Sponsor: Dren Bio
Austin, TX · Dallas, TX · San Antonio, TX · +7 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Austin, TX · Houston, TX · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.